메뉴 건너뛰기




Volumn 37, Issue 3, 2001, Pages 215-217

Hepatitis B vaccine: Risks and benefits of universal neonatal vaccination

Author keywords

Adverse events; Eradication; Hepatitis B; Neonate; Vaccines

Indexed keywords

HEPATITIS B VACCINE; PRESERVATIVE; THIOMERSAL;

EID: 0034931854     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2001.00639.x     Document Type: Review
Times cited : (9)

References (29)
  • 1
    • 0029115078 scopus 로고
    • Global programme for control of hepatitis B infection
    • (1995) Vaccine , vol.13 , Issue.SUPPL. 1
    • Kane, M.1
  • 2
    • 0004186635 scopus 로고
    • Report No. 3303.0. Australian Bureau of Statistics, Canberra
    • (1995) Causes of Death
  • 3
    • 0003607565 scopus 로고    scopus 로고
    • World Health Organization, Geneva
    • (2000) Hepatitis B
  • 9
  • 15
    • 0032247031 scopus 로고    scopus 로고
    • Universal or selective immunisation against hepatitis B virus in the United Kingdom? A review of recent cost-effectiveness studies
    • (1998) Comm. Dis. Publ. Health , vol.1 , pp. 221-228
    • Edmunds, W.J.1
  • 24
    • 0034647368 scopus 로고    scopus 로고
    • Summary of the joint statement on thimerosal in vaccines
    • American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, Public Health Service
    • (2000) MMWR , vol.49 , pp. 622
  • 25


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.